
Product News
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025
Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.

Product News
Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities
Dovetail Genomics, announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research.

Product News
Landmark Study at Homerton University Hospital Confirms GastroPanel®’s Diagnostic Accuracy
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients.

Product News
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement With LINDIS Biotech for the Commercial Supply of Catumaxomab
Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech.

Product News
Defined Hydrogel Enables Reproducible Culture of Cancer Cells in Xenograft Models
AMSBIO has launched MatriMix for PDX, a fully defined extracellular matrix (ECM) hydrogel comprising of collagen, laminin-511 E8 fragments and hyaluronic acid optimized to support patient-derived xenograft (PDX) studies.

Product News
Geneoscopy Closes $105M in Series C Funding Round To Power Next-Generation of Gastrointestinal Diagnostic Tests
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease.

Product News
AMSBIO Invest in Future US Life Scientists
AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program.

Product News
Validated Tumor Tissue Samples for Cancer Research
CancerSeq™ FFPE tissues from AMSBIO are pre-screened tumor tissue samples for single nucleotide polymorphisms (SNP’s), insertions and deletions plus copy number variations (CNVs) using targeted Next Generation Sequencing to identify key mutations.

Product News
Bio-Rad Demonstrates Leadership Position in the Oncology Market at Association for Molecular Pathology 2024
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced updates on its oncology assay portfolio and regulatory milestones, ahead of its presence at the AMP 2024 meeting.

Product News
Transgene and ProBioGen Join Forces To Advance Individualized Cancer Vaccine Development
Transgene and ProBioGen, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line.
Advertisement